Consun Pharmaceutical Group Ltd. held an extraordinary general meeting on December 23, 2025. At the meeting, shareholders approved the adoption of the Share Award Scheme and also approved the adoption of the sublimit for Service Providers under the scheme.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Consun Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251223-11965657), on December 23, 2025, and is solely responsible for the information contained therein.
Comments